-
Mashup Score: 5The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond - Current Hematologic Malignancy Reports - 2 year(s) ago
Purpose of Review The coronavirus disease 2019 (COVID-19) pandemic has had profound impacts upon scientific discourse in our field, most prominently through the abrupt transition of malignant hematology conferences to all-digital formats. These virtual components will likely be incorporated into future iterations of these conferences even as in-person attendance is reincorporated. In this review,…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia - Current Hematologic Malignancy Reports - 2 year(s) ago
Purpose of Review Despite recent advances in the treatment of de novo acute myeloid leukemia (AML), AML arising from antecedent chronic myelomonocytic leukemia (CMML) continues to have dismal outcomes. While the unique biological drivers of CMML and subsequent leukemic transformation (LT) have been revealed with advances in molecular characterization, this has not yet translated to the bedside….
Categories: Hem/Oncs, Latest HeadlinesTweet-
Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia #CMML #leusm https://t.co/eoROcSCgqt
-
-
Mashup Score: 0
Purpose of Review Despite considerable advances in the treatment of multiple myeloma (MM) in the last decade, a significant number of patients still progress on current available therapies. Here, we review treatment modalities used to target BCMA in the treatment of MM, specifically antibody-drug conjugates (ADC), bispecific antibody constructs, and chimeric antibody receptor (CAR) modified…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Targeting BCMA in Multiple Myeloma [Aug 25, 2021] Tan & @UrviShahMD Current Hematologic Malignancy Reports https://t.co/lAhqwwa7u3 #mmsm #caxtx #CARTcell
-
-
Mashup Score: 2Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges - Current Hematologic Malignancy Reports - 3 year(s) ago
Purpose of Review Social media platforms such as Twitter are increasingly utilized to interact, collaborate, and exchange information within the academic medicine community. However, as Twitter begins to become formally incorporated into professional meetings, educational activities, and even the consideration of academic promotion, it is critical to better understand both the benefits and…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges [Nov 11, 2020] @JessicaLittleMD @romeerizwan Current Hematologic Malignancy Reports https://t.co/M1hHiRSsFW PDF: https://t.co/npoH3FZQtY #socialoncology HT @DrChoueiri
-
-
Mashup Score: 1Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia - Current Hematologic Malignancy Reports - 3 year(s) ago
Purpose of Review Despite recent advances in the treatment of de novo acute myeloid leukemia (AML), AML arising from antecedent chronic myelomonocytic leukemia (CMML) continues to have dismal outcomes. While the unique biological drivers of CMML and subsequent leukemic transformation (LT) have been revealed with advances in molecular characterization, this has not yet translated to the bedside….
Categories: Hem/Oncs, Latest HeadlinesTweet-
1/4: What does acriflavine, an antiseptic dye developed in 1912, have to do with blast-phase CMML (CMML-BP)🧐? Find out in our CHMR review re: current and future therapies for AML-MRC post CMML, a particularly recalcitrant form of secondary AML (sAML): 👉https://t.co/huSc8DCQQb https://t.co/2a8Use75xV
-
-
Mashup Score: 6
Purpose of Review Despite considerable advances in the treatment of multiple myeloma (MM) in the last decade, a significant number of patients still progress on current available therapies. Here, we review treatment modalities used to target BCMA in the treatment of MM, specifically antibody-drug conjugates (ADC), bispecific antibody constructs, and chimeric antibody receptor (CAR) modified…
Categories: Latest Headlines, Oncologists1Tweet-
Our latest review on Targeting BCMA in Multiple Myeloma just published @CarlynRTanMD @SpringerNature @SpringerCurRpts @MyelomaDrKapoor @sloan_kettering @MSKHemOncTrials #mmsm #Immunotherapy https://t.co/xXzqUQxAVu
-
-
Mashup Score: 0Progress in the Management of Smoldering Multiple Myeloma - 3 year(s) ago
Purpose of Review Smoldering multiple myeloma (SMM) is defined as an asymptomatic clonal proliferation of pre-malignant plasma cells and an increased risk of progression to multiple myeloma (MM) relative to monoclonal gammopathy of undetermined significance. Whether patients with SMM should be treated prior to development of symptomatic disease is fiercely debated and is a highly active area of…
Categories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/bciYB27npb Stellar work by @TMSchmidtMD- a balanced perspective on smoldering myeloma. There are some additional limitations that @AaronGoodman33 will highlight in some upcoming work!
-
-
Mashup Score: 2The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond - 3 year(s) ago
Purpose of Review The coronavirus disease 2019 (COVID-19) pandemic has had profound impacts upon scientific discourse in our field, most prominently through the abrupt transition of malignant hematology conferences to all-digital formats. These virtual components will likely be incorporated into future iterations of these conferences even as in-person attendance is reincorporated. In this review,…
Categories: Hem/Oncs, Latest HeadlinesTweet-
The Democratization of Scientific Conferences:Twitter in the Era of #COVID-19 & Beyond | SpringerLink | @RahulBanerjeeMD @amarkelkar @hemedoc @BldCancerDoc @doctorpemm | #medtwitter #bmtsm #mmsm #leusm #MPNSM #BPDCN https://t.co/pX0hEDEmNh
-
-
Mashup Score: 24Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis — Chronic Myelomonocytic Leukemia and Beyond - 3 year(s) ago
Purpose of Review Monocytosis is a distinct but non-specific manifestation of various physiologic and pathologic conditions. Among hematopoietic stem cell neoplasms, depending on the criteria used for disease classification, monocytosis may be a consistent and integral component of diseases such as chronic myelomonocytic leukemia or acute myeloid leukemia with monocytic differentiation, or it may…
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @SibaElHussein: Our review of updates in neoplastic monocytosis, including CMML and beyond, is now out ➡️https://t.co/PVBaZzu8l2 with @s…
-
-
Mashup Score: 6Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis — Chronic Myelomonocytic Leukemia and Beyond - 3 year(s) ago
Purpose of Review Monocytosis is a distinct but non-specific manifestation of various physiologic and pathologic conditions. Among hematopoietic stem cell neoplasms, depending on the criteria used for disease classification, monocytosis may be a consistent and integral component of diseases such as chronic myelomonocytic leukemia or acute myeloid leukemia with monocytic differentiation, or it may…
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @SibaElHussein: Our review of updates in neoplastic monocytosis, including CMML and beyond, is now out ➡️https://t.co/PVBaZzu8l2 with @s…
-
#ASH21 2of2. Posting these 2 papers helpful for conference use 👉The Democratization of Scientific Conferences:Twitter in the Era of COVID-19&Beyond | @RahulBanerjeeMD @amarkelkar @hemedoc @BldCancerDoc @doctorpemm https://t.co/pX0hEDEmNh